Cargando…
Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth
Chemokinostatin-1 (CKS1) is a 24-mer peptide originally discovered as an anti-angiogenic peptide derived from the CXCL1 chemokine. Here, we demonstrate that CKS1 acts not only as an anti-angiogenic peptide but also as an oncolytic peptide due to its structural and physical properties. CKS1 induced b...
Autores principales: | Furukawa, Natsuki, Yang, Wendy, Chao, Alex, Patil, Akash, Mirando, Adam, Pandey, Niranjan, Popel, Aleksander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602061/ https://www.ncbi.nlm.nih.gov/pubmed/37886580 http://dx.doi.org/10.21203/rs.3.rs-3335225/v1 |
Ejemplares similares
-
Suppression of Ocular Vascular Inflammation through Peptide-Mediated Activation of Angiopoietin-Tie2 Signaling
por: Mirando, Adam C., et al.
Publicado: (2020) -
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide
por: Mirando, Adam C., et al.
Publicado: (2020) -
The oncolytic peptide LTX-315 triggers immunogenic cell death
por: Zhou, H, et al.
Publicado: (2016) -
Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma
por: Barbhuiya, Mustafa A., et al.
Publicado: (2017) -
An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia
por: Norton, Kerri-Ann, et al.
Publicado: (2017)